DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats

The Journal of Pharmacology and Experimental Therapeutics
Koji MatsumotoKatsuyoshi Chiba

Abstract

G protein-coupled receptor 119 (GPR119) has been shown to be highly expressed in small intestinal L-cells and pancreatic β-cells and mediates intracellular cAMP concentration, glucagon-like peptide (GLP-1) secretion, and glucose-stimulated insulin secretion (GSIS). This study examined the pharmacological effects of 4-(5-{(1R)-1-[4-(cyclopropylcarbonyl) phenoxy]propyl}-1,2,4-oxadiazol-3-yl)-2-fluoro-N-[(2R)-1-hydroxypropan-2-yl]benzamide (DS-8500a), a novel, orally available, selective GPR119 agonist. In in vitro studies, DS-8500a increased intracellular cAMP in a concentration-dependent manner in human, rat, and mouse GPR119-expressing Chinese hamster ovary (CHO)-K1 cells, with EC50 values of 51.5, 98.4, and 108.1 nmol/l, respectively. DS-8500a had no effect on intracellular cAMP in pcDNA3.1/CHO-K1 cells. In in vivo studies, DS-8500a augmented plasma GLP-1 concentration in Zucker fatty (ZF) rats, and enhanced GSIS and did not change plasma glucose concentration in fasted Sprague-Dawley (SD) rats. A single dose of DS-8500a showed dose-dependent glucose-lowering effects at oral glucose tolerance test (OGTT) in ZF rats. In a repeat-dosing study, DS-8500a had statistically significant glucose-lowering effects at OGTT performed at t...Continue Reading

References

Nov 22, 1997·European Journal of Pharmacology·L LadrièreW J Malaisse
Dec 21, 2004·Biochemical and Biophysical Research Communications·Takatoshi SogaKiyoshi Furuichi
Aug 6, 2005·Biochemical and Biophysical Research Communications·Hagit ShapiroMichael D Walker
Apr 23, 2008·Endocrinology·L LaufferP L Brubaker
Sep 29, 2009·Expert Opinion on Therapeutic Patents·Robert M JonesJuerg Lehmann
Oct 13, 2009·Diabetes, Obesity & Metabolism·S SeinoT Shibasaki
Jul 23, 2011·The Journal of Clinical Endocrinology and Metabolism·Katrine B HansenHarald S Hansen
Oct 27, 2017·Chemical Biology & Drug Design·Daniel Alencar RodriguesCarlos Alberto Manssour Fraga

❮ Previous
Next ❯

Citations

Jan 27, 2021·International Journal of Molecular Sciences·Dong-Soon Im
Jan 27, 2021·Nature Reviews. Endocrinology·Julien Ghislain, Vincent Poitout
Mar 19, 2020·Cell Metabolism·Ruth E GimenoRandy J Seeley
May 29, 2021·Bioorganic Chemistry·Ajay ManaithiyaImran A Khan
Jul 9, 2021·Cellular & Molecular Biology Letters·Jianan ZhaoJinghua Peng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.